Results 1 to 10 of about 1,206,872 (343)

Relationship between intraocular pressure and parameters of obesity in ocular hypertension [PDF]

International Journal of Ophthalmology, 2020
AIM: To evaluate the correlation between intraocular pressure (IOP) and various obesity-related health factors in patients with ocular hypertension in Korea. METHODS: A total of 40 850 subjects underwent age, sex, body weight, and height assessments and
Min Won Ahn, Ji Woong Lee, Jong Hoon Shin, Jong Soo Lee   +3 more
doaj   +2 more sources

Malignant Hypertension: Ocular Manifestations [PDF]

The Scientific World Journal, 2006
Malignant hypertension may be the first manifestation of systemic hypertension. We report a clinical case of a Caucasian 41-year-old man with no previous history of blood hypertension seen at casualty because of blurred vision.
Silvia Muñoz, Nieves Martín, Jorge Arruga   +2 more
doaj   +3 more sources

The Ocular Hypertension Treatment Study [PDF]

A M A Archives of Ophthalmology, 2002
Michael A. Kass
openalex   +2 more sources

Intraocular pressure modifications in patients with acute central/hemicentral retinal vein occlusions [PDF]

International Journal of Ophthalmology, 2021
Intraocular pressure (IOP) modifications in patients with acute central/hemicentral retinal vein occlusions (RVOs) consist in IOP reductions and increases.
Dan Calugaru, Mihai Calugaru
doaj   +1 more source

Glucocorticoid-Induced Ocular Hypertension and Glaucoma [PDF]

Clinical Ophthalmology
Devon Hori Harvey,1,2 Chenna Kesavulu Sugali,1,2 Weiming Mao1– 5 1Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA; 2Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN,
Harvey DH, Sugali CK, Mao W
doaj   +2 more sources

Ocular hypertension and severe intraocular pressure elevation after posterior subtenon injection of triamcinolone acetonide for various diseases [PDF]

International Journal of Ophthalmology, 2020
AIM: To evaluate and compare the incidences of ocular hypertension and severe intraocular pressure (IOP) elevation after posterior subtenon injection of triamcinolone acetonide (PSTA) for various diseases.
Yun-Hsiang Yang, Hua-Hsuan Kuo, Wei-Cherng Hsu, Yi-Ting Hsieh   +3 more
doaj   +1 more source

Consensus Recommendation for Mouse Models of Ocular Hypertension to Study Aqueous Humor Outflow and Its Mechanisms

Investigative Ophthalmology and Visual Science, 2022
Due to their similarities in anatomy, physiology, and pharmacology to humans, mice are a valuable model system to study the generation and mechanisms modulating conventional outflow resistance and thus intraocular pressure.
Colleen M. McDowell, K. Kizhatil, M. Elliott, D. Overby, Joseph van Batenburg-Sherwood, J. Millar, M. Kuehn, G. Zode, T. Acott, Michael G. Anderson, S. Bhattacharya, Jacques A. Bertrand, Terete Borrás, Diane E. Bovenkamp, Lin Cheng, J. Danias, Michael L. De Ieso, Yiqin Du, Jennifer A. Faralli, R. Fuchshofer, Preethi S. Ganapathy, H. Gong, S. Herberg, Humberto Hernandez, P. Humphries, S. John, P. Kaufman, Kate E. Keller, M. Kelley, R. Kelly, D. Križaj, Ajay Kumar, B. Leonard, R. Lieberman, P. Liton, Yutao Liu, Katy C. Liu, Navita N. Lopez, Weiming Mao, T. Mavlyutov, Fiona S. McDonnell, G. McLellan, Philip Mzyk, Andrews Nartey, L. Pasquale, Gaurang C. Patel, P. Pattabiraman, D. M. Peters, VijayKrishna Raghunathan, P. Rao, N. Rayana, Urmimala Raychaudhuri, Ester Reina-Torres, R. Ren, D. Rhee, U. R. Chowdhury, J. Samples, E. Samples, N. Sharif, J. Schuman, V. Sheffield, Cooper Stevenson, Avinash Soundararajan, Preeti Subramanian, Chenna Kesavulu Sugali, Yang Sun, C. Toris, Karen Y. Torrejon, A. Vahabikashi, Janice A. Vranka, Ting Wang, C. Willoughby, Chen Xin, Hongmin Yun, Hao F. Zhang, M. Fautsch, E. Tamm, A. Clark, C. Ethier, W. Stamer   +79 more
semanticscholar   +1 more source

Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis

eLife, 2021
Glucocorticoids are widely used as an ophthalmic medication. A common, sight-threatening adverse event of glucocorticoid usage is ocular hypertension, caused by dysfunction of the conventional outflow pathway.
Guorong Li, Chanyoung Lee, A Thomas Read, Ke Wang, Jungmin Ha, Megan Kuhn, Iris Navarro, Jenny Cui, Katherine Young, Rahul Gorijavolu, Todd Sulchek, Casey Kopczynski, Sina Farsiu, John Samples, Pratap Challa, C Ross Ethier, W Daniel Stamer   +16 more
doaj   +1 more source

Detecting Glaucoma in the Ocular Hypertension Study Using Deep Learning.

JAMA ophthalmology, 2022
Importance Automated deep learning (DL) analyses of fundus photographs potentially can reduce the cost and improve the efficiency of reading center assessment of end points in clinical trials.
Rui Fan, C. Bowd, Mark Christopher, Nicole Brye, J. Proudfoot, Jasmin Rezapour, A. Belghith, M. Goldbaum, B. Chuter, C. Girkin, M. Fazio, J. Liebmann, R. Weinreb, M. Gordon, M. Kass, D. Kriegman, L. Zangwill   +16 more
semanticscholar   +1 more source

Long-Term Intraocular Pressure-Lowering Effects and Adverse Events of Ripasudil in Patients with Glaucoma or Ocular Hypertension over 24 Months

Advances in Therapy, 2022
Glaucoma is a leading cause of irreversible blindness and ripasudil was the first Rho kinase inhibitor approved as antiglaucoma medication. Here we present the final analysis of the ROCK-J study, a large-scale post-marketing surveillance study to ...
H. Tanihara, Takahiko Kakuda, Tetsuro Sano, T. Kanno, Yuji Kurihara   +4 more
semanticscholar   +1 more source